One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

Haemophilia

Volumn 14, Issue 5, 2008, Pages 1049-1054

  Cid, Ana Rosa ^a   Calabuig, M ^a   Cortina, V ^a   Casana P ^a   Haya, S ^a   Moret, A ^a   Cabrera, N ^a   Aznar, J A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

FVIII assay discrepancies; Gene mutations; Haemorrhagic tendency; Mild haemophilia A

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; HISTIDINE; LEUCINE; PHENYLALANINE; PROLINE; SERINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASSAY; BLEEDING; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; FAMILY; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HEMOPHILIA A; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SCHOOL CHILD;

ADOLESCENT; ADULT; BLOOD COAGULATION TESTS; CHILD; CHROMOGENIC COMPOUNDS; FACTOR VIII; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 51249089221     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01781.x     Document Type: Article

References (20)

1. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendations of the Scientific Subcommittee on FVIII and factor IX of the SSC of ISTH. Thromb Haemost 2001; 85: 560.
2. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assay procedure. J Lab Clin Med 1953; 41: 637-47.
3. Biggs R, Eveling J, Richards G. The assay of antihaemophilic-globulin activity. Br J Haematol 1955; 1: 20-34.
4. Seghatchian MJ, Miller-Andersson M. A colorimetric evaluation on factor VIII:C potency. Med Lab Sci 1978; 35: 347-54.
5. Hathaway WE, Christian MJ, Jacobson LJ. Variant mild haemophilia. Discrepancy in one stage and two stage factor VIII assays. Thromb Haemost 1983; Suppl 50: 357 (Abst 1123).
6. Parquet-Gernez A, Mazurier C, Goudemand M. Functional and immunological assays of FVIII in 133 haemophiliacs-characterization of a subgroup of patients with mild haemophilia A and discrepancy in 1- and 2-stage assays. Thromb Haemost 1988; 59: 202-6.
7. Duncan EM, Duncan BM, Tunbridge LJ, Lloyd JV. Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A. Br J Haematol 1994; 87: 846-8.
8. Goodeve AC, Peake IR. The molecular basic of hemophilia A: genotype-phenotype relationships and inhibitor development. Semin Thromb Haemost 2003; 29: 23-30.
9. Rudzki Z, Duncan EM, Casey GJ, Neumann M, Favaloro EJ, Lloyd JV. Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods. Br J Haematol 1996; 94: 400-6.
10. Mazurier C, Gaucher C, Jorieux S, Parquet-Gernez A. Mutations in the FVIII gene in seven families with haemophilia A. Br J Haematol 1997; 96: 426-7.
11. Keeling DM, Sukhu K, Kemball-Cook G, Waseem N, Bagnall R, Lloyd JV. Diagnostic importance of the two-stage factor VIII:C assay demonstrated by a case of mild haemophilia associated with His 1954 →Leu substitution in the factor VIII A3 domain. Br J Haematol 1999; 105: 1123-6.
12. Schwaab R, Oldenburg J, Kemball-Cook G, et al. Assay discrepancy in mild haemophilia A due to a factor VIII missense mutation (Asn694Ile) in a large Danish family. Br J Haematol 2000; 109: 523-8.
13. Roelse JC, de Laaf RTM, Mertens K, van Mourik JA, Oldenburg J, Voorberg J. Altered sensitivity towards factor IXa explains assay discrepancies in plasma of haemophilia A patients with a Glu 720 →Lys substitution in factor VIII. Thromb Haemost 1999; Suppl: Abstract 5.
14. Goodeve AC, Hinks JL, Nesbitt IM, et al. Unusual discrepant factor VIII:C assays in haemophilia A patients with Tyr346Cys and Glu321Lys FVIII gene mutations. Thromb Haemost 2001; Suppl: Abstract P1370.
15. Jacquemin M, De Maeyer M, D'Orion R, Lavend'Homme R, Peerlinck K, Saint-Remy J-M. Molecular mechanisms of mild and moderate hemophilia A. J Thromb Haemost 2003; 1: 456-63.
16. Pipe SW, Eickhorst AN, McKinley SH, Saenko EL, Kaufman RJ. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: Evidence for nonproteolytic inactivation of factor VIIIa in vivo. Blood 1999; 93: 176-83.
17. Pipe SW, Saenko EL, Eickhorst AN, Kembal-Cook G, Kaufman RJ. Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa. Blood 2001; 97: 685-91.
18. Cid AR, Casaña P, Cabrera N, Haya S, Cortina V, Aznar JA. Inhibitor development in one patient and laboratory discrepancies in several families with both mild haemophilia and Arg531Cys mutation. Haemophilia 2007; 13: 206-8.
19. Schwaab R, Oldenburg J, Schwaab U, et al. Characterization of mutations within the factor VIII gene of 73 unrelated mild and moderate haemophiliacs. Br J Haematol 1995; 91: 458-64.
20. Van Den Berg HM, De Groot PHG, Fischer K. Phenotypic heterogeneity in severe hemophilia. J Thromb Haemost 2007; 5(Suppl 1): 151-6.